インドの術中放射線療法市場の評価：製品・サービス別、技術別、用途別、エンドユーザー別、地域別、機会および予測、2018～2032年

インドの術中放射線療法市場は、2025～2032年度の予測期間中にCAGR 7.50％を記録し、2024年度の159万米ドルから2032年度には283万米ドルに成長すると予測されています。同市場の成長を支えているのは、同国におけるがん患者の増加、研究開発活動への投資の増加、ヘルスケア部門のアップグレードへの注目の高まり、高度な治療ソリューションの提供を後押しする主要企業の取り組みの活発化です。また、インド政府はがん治療施設やヘルスケア・インフラのアップグレードに積極的に投資しており、患者が高度な治療やサービスを受けられるようにし、治療成績の向上に努めています。さらに、医療従事者や対象となる患者集団の間で術中放射線療法に対する認識が高まっていることも、同技術の受け入れ拡大に寄与しています。

一方、国内のさまざまな病院も、新しい術中放射線療法を確実に利用できるようにするための取り組みを強化しています。例えば、2024年5月、カルナタカ州バンガロールにあるラマイア記念病院は、2件の乳房温存がん手術を成功させ、外科的切除後、腫瘍床に精密な術中放射線療法を一度に照射するための術中放射線療法用X線装置を使用しました。術中放射線療法は、長期にわたる外部照射療法の必要性を最小限に抑える有望な選択肢として浮上してきました。この治療と乳房温存手術を併用することで、早期乳がんの患者に効果的で正確な治療を提供し、患者の転帰を改善し、放射線治療の必要性を減らすことができます。

さらに、インドの主要ヘルスケア機関や研究機関は、より多くの患者が必要な治療オプションを利用できるようにするため、費用効率が高く革新的な術中放射線療法ソリューションを開発するための協力関係をますます強めています。このような取り組みがインドの技術革新を促進し、インド術中放射線療法市場に有利な成長機会をもたらすと期待されています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 インドの術中放射線療法市場の見通し、2018年～2032年

• 市場規模の分析と予測
  • 金額別
• 市場シェア分析と予測
  • 製品・サービス別
    • 製品
    • サービス
  • 技術別
    • 電子IORT
    • 術中小線源治療
  • 用途別
    • 乳がん
    • 脳腫瘍
    • 消化器がん
    • 頭頸部がん
    • 大腸がん
    • 子宮頸がん
    • 肺がん
    • その他のがんの種類
  • エンドユーザー別
    • 病院
    • 専門クリニック
    • その他
  • 地域別
    • 北部
    • 東部
    • 南部
    • 西部と中央部
  • 市場シェア分析（上位5社およびその他- 金額別、2024年）、企業別
• 市場マップ分析、2024年
  • 製品・サービス別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 需要供給分析

第6章 バリューチェーン分析

第7章 ポーターのファイブフォース分析

第8章 PESTLE分析

第9章 価格分析

第10章 市場力学

• 市場促進要因
• 市場の課題

第11章 市場の動向と発展

第12章 規制枠組みとイノベーション

• 臨床試験
• 規制当局の承認

第13章 特許の情勢

第14章 ケーススタディ

第15章 競合情勢

• 市場リーダー上位5社の競合マトリックス
• 上位5社のSWOT分析
• 市場上位10社の主要企業の情勢
  • Elekta Medical Systems India Pvt. Ltd.
  • 会社概要
  • 主要経営陣
  • 製品とサービス
  • 財務状況（報告通り）
  • 主な市場フォーカスと地理的プレゼンス
  • 最近の動向/コラボレーション/ パートナーシップ/合併と買収
  • Becton Dickinson India Private Limited
  • Sensus Healthcare, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Carl Zeiss AG
  • Eckert &Ziegler SE
  • Sordina IORT Technologies SpA
  • Ariane Medical Systems Ltd.
  • Varian Medical Systems, Inc.

上記の企業は市場シェアに基づいて注文を保留しておらず、調査作業中に入手可能な情報に基づいて変更される可能性があります。

第16章 戦略的提言

第17章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Intraoperative Radiation Therapy Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Intraoperative Radiation Therapy Market Share (%), By Products and Services, FY2018-FY2032F
• Figure 3. India Intraoperative Radiation Therapy Market Share (%), By Technology, FY2018-FY2032F
• Figure 4. India Intraoperative Radiation Therapy Market Share (%), By Application, FY2018-FY2032F
• Figure 5. India Intraoperative Radiation Therapy Market Share (%), By End-user, FY2018-FY2032F
• Figure 6. India Intraoperative Radiation Therapy Market Share (%), By Region, FY2018-FY2032F
• Figure 7. By Products and Services Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By Technology Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 11. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024

India intraoperative radiation therapy market is projected to witness a CAGR of 7.50% during the forecast period FY2025-FY2032, growing from USD 1.59 million in FY2024 to USD 2.83 million in FY2032. The market's growth is supported by the rising cases of cancer in the country, increasing investments in research and development activities, growing focus on the upgradation of the healthcare sector, and increasing efforts of the leading healthcare companies to boost the availability of advanced treatment solutions. Additionally, the government of India is proactively investing in the upgradation of cancer treatment facilities and healthcare infrastructure to ensure that the patient population has access to advanced care, services, and treatment outcomes are improved. Furthermore, the growing awareness about intraoperative radiation therapies among healthcare professionals and target patient populations is contributing to the increasing acceptance of technology.

Meanwhile, various hospitals across the country are also strengthening their efforts to ensure the availability of novel intraoperative radiation therapies. For instance, in May 2024, Ramaiah Memorial Hospital in Bangalore, Karnataka, successfully conducted two breast conservation cancer surgeries and used an intraoperative radiation therapy x-ray device for delivering precision intraoperative radiation therapy to tumor bed in a single sitting following the surgical resection. Intraoperative radiation therapy has emerged as a promising option for minimizing the requirement for prolonged external beam radiation therapy. The therapy in combination with breast conservation surgery provides effective and precise treatment for patients suffering from early-stage breast cancer, improving patient outcomes and reducing the requirement for radiation therapy.

Furthermore, leading Indian healthcare organizations and research institutions are increasingly collaborating for creating cost-efficient and innovative intraoperative radiation therapy solutions, to ensure that a wider group of patients has access to the necessary treatment options. Such efforts are expected to foster innovation in the country and provide lucrative growth opportunities to the India intraoperative radiation therapy market.

Rapid Adoption of Novel Treatment Solutions by Hospitals to Bolster Market Demand

Hospitals and medical centers across the country are increasingly investing towards advanced technologies such as intraoperative radiation therapy procedures to ensure accurate delivery of radiation during surgical procedures, thus enhancing treatment effectiveness by minimizing damage across the surrounding healthy tissues.

For instance, in June 2023, Fortis Hospital in Bangalore successfully conducted India's first novel intraoperative radiation therapy procedure on a patient suffering from recurrent glioblastoma for the past two years. The increasing awareness about the availability of such advanced therapeutic solutions among both healthcare professionals and patients is expected to bolster the India intraoperative radiation therapy market demand.

Increasing Investments in Radiation Therapy Support Market Expansion

Various leading medical institutes in the country are significantly investing towards radiation therapy systems boosting the India intraoperative radiation therapy market size. In November 2023, the Krishna Institute of Medical Sciences in Hyderabad, Telangana ordered a radiation therapy system worth USD 40 million from Elekta Medical Systems India Pvt. Ltd. The available software and devices allow the institute of medical sciences to provide cutting-edge technologies to the patient population and provide them with precise and personalized treatment solutions. Such investments enable medical professionals to ameliorate the quality of life of patients suffering from chronic conditions, ensuring that they are provided with the best possible care available. Thus, bolstering the demand for intraoperative radiation therapy products and services and positively influencing the market's expansion.

Electron IORT to Register Significant Market Growth in the Future

Electron IORT delivers radiation directly to the tumor site during surgery, ensuring precise targeting of malignant tissues while preserving adjacent healthy tissues. This focused method reduces collateral damage, making it particularly beneficial for treating tumors in sensitive areas such as the breast and gastrointestinal tract. One of the major benefits of electron IORT is the reduction in overall treatment duration. By administering radiation during surgery, patients can avoid numerous post-operative radiation sessions. This efficiency is advantageous for both healthcare providers and patients, promoting faster recovery and shorter hospital stays. Clinical studies indicate that electron IORT can result in better local disease control and lower recurrence rates compared to conventional external beam radiation therapy. The ability to deliver a high dose of radiation accurately during surgery improves treatment effectiveness, contributing to its increasing popularity and supporting the expansion of the segment. Growing awareness among healthcare professionals coupled with rising adoption of this treatment in healthcare facilities to drive the segment growth in the market.

Breast Cancer Anticipated to Hold Significant Market Share

The rising prevalence of breast cancer is augmenting the requirement for advanced therapeutic solutions including intraoperative radiation therapies in the country. According to an article published in Cancer (an international interdisciplinary journal of the American Cancer Society) in January 2024, breast cancer is the most common type of cancer in India among women and accounts for around 25% of all cancers in the female population in the country.

Moreover, according to the Globocan (Global Cancer Repository of WHO) data, there were 192,020 breast cancer cases diagnosed in India. Intraoperative radiation therapy has the advantage of potentially reducing non-compliance to post-operative radiation by delivering a single dose at the time of surgery. The therapy offers various benefits to women with breast cancer that have progesterone and estrogen-receptor-positive tumor and provides effective outcomes by eliminating cancer cells immediately after the surgical procedure. Additionally, the radiation is delivered throughout one small session, ensuring the completion of the treatment at a significantly faster rate than traditional radiation.

Future Market Scenario (FY2025 - FY2032F)

According to India intraoperative radiation therapy market analysis, the market is expected to witness a significant increase in demand in the coming years due to the rising cases of cancer, increasing investments towards the enhancement of healthcare facilities, and growing public awareness about the various treatments available. As per the estimates of the Global Cancer Observatory (Globocan), cancer cases in India will increase by 57.5% between 2040 and 2020.

Integration of advanced technologies such as machine learning and artificial intelligence with intraoperative radiation therapy systems is expected to aid the healthcare industry in increasing the accessibility of treatment solutions in the country.

Increasing collaborations between leading players of the market and global healthcare organizations are anticipated to ensure the development of advanced technological solutions, enhancing the quality of care provided to the patient population.

Investments in training medical professionals would be essential to ensure that they are equipped with the necessary skills to operate advanced technological solutions.

The rising number of multispecialty hospitals in the country is expected to bolster the demand for advanced oncology techniques, further providing lucrative growth opportunities to the India intraoperative radiation therapy market.

Key Players Landscape and Outlook

Leading integrated healthcare companies in the country are increasingly working on implementing intraoperative radiation therapies, providing lucrative growth opportunities for the market.

In October 2024, Aster DM Healthcare Limited became the first in the country to implement intraoperative electron, making a significant shift in cancer care. By targeting remaining microscopic cancer cells in quick succession with the tumor removal process, the chances of survival increase significantly along with recovery time. Such efforts to bolster the availability of advanced treatment solutions in India are expected to aid the country in combatting the growing threat of cancer and positively influence the market's expansion.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Intraoperative Radiation Therapy Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Products and Services
    • 4.2.1.1. Products
      • 4.2.1.1.1. Systems/Accelerators
      • 4.2.1.1.2. Applicators and Afterloaders
      • 4.2.1.1.3. Treatment Planning Systems
      • 4.2.1.1.4. Accessories
    • 4.2.1.2. Services
  • 4.2.2. By Technology
    • 4.2.2.1. Electron IORT
    • 4.2.2.2. Intraoperative Brachytherapy
  • 4.2.3. By Application
    • 4.2.3.1. Breast Cancer
    • 4.2.3.2. Brain Tumor
    • 4.2.3.3. Gastrointestinal Cancer
    • 4.2.3.4. Head and Neck Cancer
    • 4.2.3.5. Colorectal Cancer
    • 4.2.3.6. Cervical Cancer
    • 4.2.3.7. Lung Cancer
    • 4.2.3.8. Other Cancer Types
  • 4.2.4. By End-user
    • 4.2.4.1. Hospitals
    • 4.2.4.2. Specialty Clinics
    • 4.2.4.3. Others
  • 4.2.5. By Region
    • 4.2.5.1. North
    • 4.2.5.2. East
    • 4.2.5.3. South
    • 4.2.5.4. West and Central
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Products and Services
  • 4.3.2. By Technology
  • 4.3.3. By Application
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

• 12.1. Clinical Trials
• 12.2. Regulatory Approvals

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. Elekta Medical Systems India Pvt. Ltd.
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 15.3.2. Becton Dickinson India Private Limited
  • 15.3.3. Sensus Healthcare, Inc.
  • 15.3.4. Panacea Medical Technologies Pvt. Ltd.
  • 15.3.5. Carl Zeiss AG
  • 15.3.6. Eckert & Ziegler SE
  • 15.3.7. Sordina IORT Technologies S.p.A.
  • 15.3.8. Ariane Medical Systems Ltd.
  • 15.3.9. Varian Medical Systems, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer